[8-K] Xeris Biopharma Holdings, Inc. Reports Material Event
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Xeris Biopharma Holdings, Inc. reported the results of its 2026 Annual Meeting of Stockholders. Of 172,625,762 common shares entitled to vote as of April 14, 2026, 128,268,073 were represented, establishing a quorum. Stockholders elected Class II directors Dawn Halkuff and John Johnson by plurality vote.
They also ratified Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2026, and approved on an advisory basis the compensation of named executive officers under the Say‑on‑Pay Vote. No other matters were submitted for stockholder action.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares entitled to vote: 172,625,762 shares
Shares represented at meeting: 128,268,073 shares
Votes for Dawn Halkuff: 62,581,577 votes
+3 more
6 metrics
Shares entitled to vote
172,625,762 shares
Common stock outstanding and entitled to vote as of April 14, 2026
Shares represented at meeting
128,268,073 shares
Shares present virtually or by proxy constituting a quorum
Votes for Dawn Halkuff
62,581,577 votes
Class II director election at 2026 Annual Meeting
Votes for John Johnson
52,665,077 votes
Class II director election at 2026 Annual Meeting
Auditor ratification votes for
125,789,818 votes
Ratification of Ernst & Young LLP for fiscal year ending December 31, 2026
Say-on-Pay votes for
82,230,204 votes
Advisory approval of named executive officer compensation
Key Terms
Emerging growth company, Broker Non-Votes, Say-on-Pay Vote, independent registered public accounting firm, +1 more
5 terms
Emerging growth company regulatory
"Emerging growth company Item 5.07 Submission of Matters to a Vote of Security Holders."
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Broker Non-Votes financial
"Class II Director Nominee | For | Withhold | Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
Say-on-Pay Vote financial
"pursuant to the Say-on-Pay Vote"
A say-on-pay vote is a shareholder advisory vote on a company’s executive compensation package, usually held at the annual meeting to approve or voice disapproval of how top managers are paid. Think of it as a feedback button for owners: while the vote is often nonbinding, a strong negative outcome warns of governance problems, can force pay-policy changes, damage board credibility and ultimately influence long-term shareholder returns.
independent registered public accounting firm financial
"ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Definitive Proxy Statement regulatory
"As described in the Company’s Definitive Proxy Statement on Schedule 14A"
A Definitive Proxy Statement is a detailed document that a company sends to its shareholders before a big meeting, like voting on important decisions. It explains what's being voted on and gives important information so shareholders can make informed choices. It matters because it helps shareholders understand and participate in key company decisions.
